Telmecaid-M50 Tablet ER
Marketer
Medicaid Labs LLP
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (50mg)
Overview Telmecaid-M50 Tablet ER
Telmecaid-M50 Extended-Release tablets manage hypertension, reducing the risk of cardiovascular events like strokes and heart attacks. Early use significantly improves heart attack survival rates. For consistent blood levels, take this medication with food at the same time daily, as directed by your physician. Continued use is crucial, even without noticeable symptoms, as hypertension is often asymptomatic; premature discontinuation can worsen your condition. Lifestyle modifications—regular exercise, weight management, and a healthy diet—complement this treatment. Adhere strictly to your doctor's instructions. Potential side effects include headache, weakness, dizziness, hypotension (sometimes with fainting), shortness of breath, nausea, vomiting, stomach pain, fatigue, and elevated potassium levels. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and change positions slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor about pre-existing liver or kidney disease, and pregnant or breastfeeding women should seek medical counsel before use. Disclose all other medications, particularly those for hypertension or heart conditions.
Primary Ingredients of Telmecaid-M50 Tablet ER
No text provided. Please provide the text you wish me to rewrite.
Uses of Telmecaid-M50 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Telmecaid-M50 Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Telmecaid-M50 Extended-Release tablets with food.
Common Side effects of Telmecaid-M50 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Telmecaid-M50 Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. It is recommended to take Telmecaid-M50 Tablet ER with a meal.
How Telmecaid-M50 Tablet ER works:
Telmisartan and Metoprolol Succinate, combined in Telmecaid-M50 Extended-Release tablets, offer a dual approach to hypertension management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmecaid-M50 Tablet ER and alcohol is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Telmecaid-M50 Extended-Release tablets is contraindicated during pregnancy due to established fetal risks. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Telmecaid-M50 tablets are likely safe for breastfeeding mothers. Available human data indicates minimal infant risk associated with the medication.
DrivingUNSAFE
Extended-release Telmecaid-M50 tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Telmecaid-M50 Extended-Release tablets without any necessary dosage modification.
LiverCAUTION
Patients with hepatic impairment should use Telmecaid-M50 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Telmecaid-M50 Tablet ER :
Should you forget a Telmecaid-M50 Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmecaid-M50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |


